Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression.

Wang W, Cheng B, Miao L, Mei Y, Wu M.

Cell Death Dis. 2013 Apr 4;4:e574. doi: 10.1038/cddis.2013.97.

2.

EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53.

Kapoor GS, Christie A, O'Rourke DM.

Cancer Biol Ther. 2007 Apr;6(4):571-9.

PMID:
17457042
3.

Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7.

Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ.

J Biol Chem. 2009 Feb 27;284(9):5731-41. doi: 10.1074/jbc.M804280200. Epub 2008 Dec 10.

4.

Coordinated targeting of the EGFR signaling axis by microRNA-27a*.

Wu X, Bhayani MK, Dodge CT, Nicoloso MS, Chen Y, Yan X, Adachi M, Thomas L, Galer CE, Jiffar T, Pickering CR, Kupferman ME, Myers JN, Calin GA, Lai SY.

Oncotarget. 2013 Sep;4(9):1388-98.

5.

ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.

Lee SY, Shin SJ, Kim HS.

Int J Oncol. 2013 Mar;42(3):1027-35. doi: 10.3892/ijo.2013.1764. Epub 2013 Jan 10.

PMID:
23314357
6.

Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.

Li XL, Jones MF, Subramanian M, Lal A.

FEBS Lett. 2014 Aug 19;588(16):2610-5. doi: 10.1016/j.febslet.2014.03.054. Epub 2014 Apr 12. Review.

8.

miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.

Lee YM, Lee JY, Ho CC, Hong QS, Yu SL, Tzeng CR, Yang PC, Chen HW.

Breast Cancer Res. 2011;13(6):R116. doi: 10.1186/bcr3059. Epub 2011 Nov 23.

9.

EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.

Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, Chen HC, Yeh SD, Wu CW.

Cancer Res. 2010 Nov 1;70(21):8822-31. doi: 10.1158/0008-5472.CAN-10-0638. Epub 2010 Oct 26.

10.

Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen.

Wang Q, Li DC, Li ZF, Liu CX, Xiao YM, Zhang B, Li XD, Zhao J, Chen LP, Xing XM, Tang SF, Lin YC, Lai YD, Yang P, Zeng JL, Xiao Q, Zeng XW, Lin ZN, Zhuang ZX, Zhuang SM, Chen W.

Oncogene. 2011 Sep 8;30(36):3875-86. doi: 10.1038/onc.2011.103. Epub 2011 Apr 4.

PMID:
21460851
11.

Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, Sudo S, Ju J, Sakuragi N.

Oncogene. 2013 Jul 4;32(27):3286-95. doi: 10.1038/onc.2012.334. Epub 2012 Jul 30.

12.

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.

Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY.

Cancer Res. 2007 Sep 15;67(18):8433-8. Epub 2007 Sep 6.

13.

MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5.

Cai C, Ashktorab H, Pang X, Zhao Y, Sha W, Liu Y, Gu X.

PLoS One. 2012;7(1):e29750. doi: 10.1371/journal.pone.0029750. Epub 2012 Jan 3.

14.

Mutant p53 drives invasion in breast tumors through up-regulation of miR-155.

Neilsen PM, Noll JE, Mattiske S, Bracken CP, Gregory PA, Schulz RB, Lim SP, Kumar R, Suetani RJ, Goodall GJ, Callen DF.

Oncogene. 2013 Jun 13;32(24):2992-3000. doi: 10.1038/onc.2012.305. Epub 2012 Jul 16.

PMID:
22797073
15.

MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.

Luan S, Sun L, Huang F.

Arch Med Res. 2010 Feb;41(2):67-74. doi: 10.1016/j.arcmed.2010.02.007.

PMID:
20470934
16.

Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.

Yan D, Dong XD, Chen X, Yao S, Wang L, Wang J, Wang C, Hu DN, Qu J, Tu L.

PLoS One. 2012;7(7):e40967. doi: 10.1371/journal.pone.0040967. Epub 2012 Jul 27.

17.

EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.

Yao W, Feng D, Bian W, Yang L, Li Y, Yang Z, Xiong Y, Zheng J, Zhai R, He J.

Amino Acids. 2012 Nov;43(5):2027-35. doi: 10.1007/s00726-012-1277-z. Epub 2012 Apr 4.

18.

Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency.

Guo SL, Ye H, Teng Y, Wang YL, Yang G, Li XB, Zhang C, Yang X, Yang ZZ, Yang X.

Nat Commun. 2013;4:2544. doi: 10.1038/ncomms3544.

19.

MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation.

Suto T, Yokobori T, Yajima R, Morita H, Fujii T, Yamaguchi S, Altan B, Tsutsumi S, Asao T, Kuwano H.

Carcinogenesis. 2015 Mar;36(3):338-45. doi: 10.1093/carcin/bgu242. Epub 2014 Dec 10.

20.

miR-449 inhibits cell proliferation and is down-regulated in gastric cancer.

Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B, Lund AH, Friis-Hansen L.

Mol Cancer. 2011 Mar 18;10:29. doi: 10.1186/1476-4598-10-29.

Items per page

Supplemental Content

Write to the Help Desk